You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

List of Excipients in API oxacillin


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing oxacillin

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Baxter Healthcare Corporation OXACILLIN oxacillin 0338-1013 DEXTROSE MONOHYDRATE
Baxter Healthcare Corporation OXACILLIN oxacillin 0338-1013 HYDROCHLORIC ACID
Baxter Healthcare Corporation OXACILLIN oxacillin 0338-1013 SODIUM HYDROXIDE
Baxter Healthcare Corporation OXACILLIN oxacillin 0338-1013 TRISODIUM CITRATE DIHYDRATE
Baxter Healthcare Corporation OXACILLIN oxacillin 0338-1013 WATER
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing oxacillin

Company Ingredient NDC Excipient
Mitim Srl oxacillin 22607-698 SODIUM PHOSPHATE, DIBASIC
Fresenius Kabi USA LLC oxacillin 63323-813 SODIUM PHOSPHATE, DIBASIC
Wockhardt USA LLC oxacillin 64679-698 SODIUM PHOSPHATE, DIBASIC
Wockhardt USA LLC oxacillin 64679-700 SODIUM PHOSPHATE, DIBASIC
Piramal Critical Care Inc oxacillin 66794-226 SODIUM PHOSPHATE, DIBASIC
Piramal Critical Care Inc oxacillin 66794-227 SODIUM PHOSPHATE, DIBASIC
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for oxacillin

Excipient focus: DEXTROSE MONOHYDRATE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM PHOSPHATE, DIBASIC

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links